Free Trial
BATS:VXZ

iPath Series B S&P 500 VIX Mid-Term Futures ETN (VXZ) Price, Holdings, & News

$59.97 -2.05 (-3.31%)
As of 05/9/2025 09:57 AM Eastern
This is a fair market value price provided by Polygon.io. Learn more.

About iPath Series B S&P 500 VIX Mid-Term Futures ETN (BATS:VXZ)

Key Stats

Today's Range
$62.58
$64.03
50-Day Range
$51.32
$67.21
52-Week Range
$47.50
$69.33
Volume
13,758 shs
Average Volume
18,863 shs
Market Capitalization
N/A
Assets Under Management
$36.72 million
Dividend Yield
N/A
Net Expense Ratio
0.00%
Aggregate Rating
N/A

ETF Overview

The iPath Series B S&P 500 VIX Mid-Term Futures ETN (VXZ) is an exchange-traded fund that is based on the S&P 500 VIX Mid-Term Futures index. The fund tracks an index with exposure to futures contracts on the CBOE Volatility Index with average five-month maturity. Exposure resets daily. VXZ was launched on Jan 17, 2018 and is issued by iPath.

iPath Series B S&P 500 VIX Mid-Term Futures ETN Expenses

TypeVXZVolatility ETFsMulti Asset ETFsBATS ETFsAll ETFs
Management Fee0.00%0.78%0.71%0.58%0.53%
Other Expenses0.00%0.36%0.72%0.44%0.52%
Total Expense0.00%0.91%1.21%0.69%0.71%
Fee Waiver0.00%0.00%-0.70%-0.34%-0.54%
Net Expense0.00%0.93%0.97%0.65%0.60%
Receive VXZ Stock News and Ratings via Email

Sign-up to receive the latest news and ratings for iPath Series B S&P 500 VIX Mid-Term Futures ETN and its competitors with MarketBeat's FREE daily newsletter.

VXZ ETF News Headlines

Why The Next Spike In Market Volatility May Last
iPath Series B S&P 500 VIX Mid-Term Futures ETN (VXZ)
URGENT: Someone's Moving Gold Out of London...
People who don’t understand the gold market are about to lose a lot of money. Unfortunately, most so-called “gold analysts” have it all wrong… They tell you to invest in gold ETFs - because the popular mining ETFs will someday catch fire and close the price gap with spot gold.
See More Headlines

VXZ ETF - Frequently Asked Questions

iPath Series B S&P 500 VIX Mid-Term Futures ETN's stock was trading at $50.5925 at the beginning of the year. Since then, VXZ shares have increased by 18.5% and is now trading at $59.9680.
View the best growth stocks for 2025 here
.

Shares of iPath Series B S&P 500 VIX Mid-Term Futures ETN reverse split on the morning of Wednesday, July 24th 2024. The 1-4 reverse split was announced on Wednesday, July 24th 2024. The number of shares owned by shareholders was adjusted after the closing bell on Wednesday, July 24th 2024. An investor that had 100 shares of stock prior to the reverse split would have 25 shares after the split.

iPath Series B S&P 500 VIX Mid-Term Futures ETN's top institutional shareholders include IMC Chicago LLC and Belvedere Trading LLC.

Shares of VXZ stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include Charles Schwab, E*TRADE, Fidelity, and Vanguard Brokerage Services.

Based on aggregate information from My MarketBeat watchlists, some other companies that iPath Series B S&P 500 VIX Mid-Term Futures ETN investors own include Meta Platforms (META), iPath Series B S&P 500 VIX Short-Term Futures ETN (VXX), Advanced Micro Devices (AMD), Citigroup (C), Salesforce (CRM), DocuSign (DOCU) and The Goldman Sachs Group (GS).

Fund Details

Issuer
Barclays Capital
Fund Name
iPath Series B S&P 500 VIX Mid-Term Futures ETN
Tax Classification
Exchange-Traded Note
Stock Exchange
BATS
Current Symbol
BATS:VXZ
Inception Date
1/17/2018
Fund Manager
N/A

Fund Focus

Asset Class
Multi Asset
Benchmark
S&P 500 VIX Short-Term Futures Index
Category
Absolute Returns
Focus
Volatility
Development Level
Developed Markets
Region
North America
Number of Holdings
0

Fund Statistics

Assets Under Management
$36.72 million
Average Daily Volume
$0.00
Discount/Premium
0.03%

Administrator, Advisor and Custodian

Administrator
N/A
Advisor
N/A
Custodian
N/A
Distributor
N/A
Transfer Agent
N/A
Trustee
N/A
Lead Market Maker
Virtu Financial

Options

Optionable
Optionable
Options Volume
7
Put Options
2
Call Options
5

Miscellaneous

Beta
-1.47
20 Stocks to Sell Now Cover

Today, we are inviting you to take a free peek at our proprietary, exclusive, and up-to-the-minute list of 20 stocks that Wall Street's top analysts hate.

Many of these appear to have good fundamentals and might seem like okay investments, but something is wrong. Analysts smell something seriously rotten about these companies. These are true "Strong Sell" stocks.

Get This Free Report

This page (BATS:VXZ) was last updated on 5/11/2025 by MarketBeat.com Staff
From Our Partners